Lawsuit Information Center

August 18, 2026

Bard PowerPort Lawsuit

Bard PowerPort lawsuits allege that defects in implanted port catheters can cause fractures, migration, blood clots, infections, embolisms, and other serious complications. Thousands of product liability lawsuits are now pending against Bard and its parent company, Becton Dickinson, in a federal multidistrict litigation in Arizona. After a long slog, these cases are now moving forward.

The first bellwether trial ended with a partial defense verdict and a deadlocked jury on the central design defect claim. The next trial, Divelbliss v. C.R. Bard, is scheduled to begin today. It involves an alleged fracture of a silicone Groshong catheter. Five bellwether trials are now expected to run through February 2027. Our lawyers remain bullish on well-documented fracture, migration, and embolization cases.

This page provides the latest Bard PowerPort lawsuit updates, projected settlement amounts, and information about who may qualify to file a claim.

August 11, 2026

Hair Relaxer Lawsuit

by Ronald V. Miller, Jr.

Our lawyers are reviewing hair relaxer cancer lawsuits on behalf of women throughout the United States. These claims involve women who used chemical hair relaxers or hair straighteners for years and were later diagnosed with uterine cancer, including endometrial cancer, ovarian cancer, or serious uterine fibroids that led to a hysterectomy.

The federal hair relaxer litigation now includes nearly 12,000 plaintiffs. The cases are moving through expert discovery and bellwether preparation in the Northern District of Illinois. No hair relaxer settlement has been announced, and no plaintiff has received a settlement payout through the federal MDL. The latest hair relaxer lawsuit update is that Judge Mary Rowland has lifted a discovery stay for a group of defendants after concluding that settlement discussions had not produced enough progress to justify keeping those cases frozen.

The strongest cases generally involve frequent, long-term use followed by uterine or ovarian cancer, a clear product history, and substantial treatment or reproductive injury.

August 6, 2026

Suboxone Tooth Decay Lawsuit Update

by Ronald V. Miller, Jr.

This page explains the Suboxone tooth decay lawsuits, the dental injuries linked to Suboxone film, and where the federal MDL stands in 2026.

The core claim in the Suboxone litigation is straightforward: plaintiffs allege that Indivior and related defendants knew, or should have known, that Suboxone film could cause severe dental damage, including tooth decay, enamel erosion, broken teeth, tooth loss, and expensive dental reconstruction. Plaintiffs contend the companies failed to warn patients and prescribing doctors until the FDA forced a dental warning in 2022.

Our firm is not accepting new Suboxone cases in 2026. This page is provided for litigation updates and general information for victims and their families

August 5, 2026

Dupixent Lawsuit for T-Cell Lymphoma

by Ronald V. Miller, Jr.

Dupixent lawsuits are now moving forward in federal court for patients who allege the drug caused, accelerated, or unmasked cutaneous T-cell lymphoma and related T-cell lymphomas. On June 4, 2026, the Judicial Panel on Multidistrict Litigation centralized the federal Dupixent cases in MDL No. 3180, In re: Dupixent (Dupilumab) Products Liability Litigation, in the District of New Jersey before Judge Zahid N. Quraishi.

Dupixent, also known as dupilumab, is a biologic medication used to treat atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, COPD, bullous pemphigoid, allergic fungal rhinosinusitis, and other inflammatory conditions. For many patients, Dupixent has provided real relief where other treatments failed. But for some patients, the story has been very different.

The lawsuits allege that Regeneron and Sanofi failed to warn doctors and patients that cutaneous T-cell lymphoma, often called CTCL, can mimic eczema and that Dupixent may mask, accelerate, or delay diagnosis of an underlying lymphoma. Plaintiffs argue that patients with adult-onset, atypical, or treatment-resistant dermatitis should have been warned to rule out lymphoma before starting Dupixent and to stop and investigate if symptoms worsened or changed during treatment.

August 4, 2026

Ozempic Lawsuit

by Ronald V. Miller, Jr.

Our lawyers are investigating Ozempic lawsuits for patients with NAION, gastroparesis, or gastrointestinal conditions, including bowel obstruction or cyclic vomiting syndrome.

Ozempic is the popular brand name for semaglutide, a prescription drug approved for the treatment of type 2 diabetes. As we all know, Ozempic is also commonly used as a weight management drug. Recent scientific studies have shown that taking Ozempic, particularly at higher doses, can cause gastroparesis.

August 4, 2026

Gambling Addiction Lawsuits

by Ronald V. Miller, Jr.

Our lawyers are investigating gambling addiction lawsuits involving DraftKings, FanDuel, BetMGM, Caesars, ESPN Bet, Bet365, Fanatics Sportsbook, Hard Rock Bet, and other online betting platforms. The central allegation is that these companies had the data to identify compulsive gambling behavior and, instead of slowing vulnerable users down, continued to push bonus bets, deposit matches, notifications, VIP offers, profit boosts, parlays, microbets, and personalized promotions.

If you or your child suffered serious harm from online sports betting addiction, the first question is not whether gambling was legal. The first question is whether the platform used design, data, and marketing to keep a vulnerable user betting when a responsible operator should have stepped in.

If you or someone you love has suffered severe financial and emotional harm because of addiction to online gambling or sports betting, contact our lawyers at 800-553-8082 or get a free, no-obligation online consultation.

August 4, 2026

Social Media Addiction Lawsuit

by Ronald V. Miller, Jr.

This page is about social media addiction lawsuits and who is eligible to bring a claim. Our lawyers also provide the latest news on social media class action lawsuits (including the ongoing trial in California).

The problem that led to social media lawsuits is that millions of people, too many of whom are children, are addicted to social media platforms such as Facebook, Instagram, Snapchat, and others. For these vulnerable users, social media addiction can be very harmful and lead to things like eating disorders, depression, and, in some cases, suicide.

Now, these companies are facing a wave of new social media lawsuits alleging that they knowingly designed the algorithms of their platforms to lure young people into harmful addictions.

August 4, 2026

Paragard IUD Lawsuit Settlement Amounts

by Ronald V. Miller, Jr.

Our lawyers are handling Paragard IUD lawsuits for women throughout the United States. These cases allege that the copper IUD can fracture during removal, leaving one or both plastic arms inside the uterus and sometimes forcing the patient to undergo another procedure or surgery.

The federal litigation now includes more than 4,000 filed cases. The first bellwether trial ended in a defense verdict in February 2026. That was a real loss for plaintiffs, and it changed the settlement calculus maybe a bit. But it is just one case, and all that can be turned around with a win in September 2026 when we have the next trial.

So there is no Paragard settlement deal as of August 2026. Our lawyers still believe these claims may eventually be resolved through a negotiated settlement, but the first defense verdict makes it harder to predict when that could happen or what defendants will be willing to pay. We discuss our estimated Paragard settlement values below.

August 4, 2026

Truvada Lawsuit

by Ronald V. Miller, Jr.

This page is about Truvada lawsuits and other HIV drug injury lawsuits involving kidney or bone injuries.

HIV drugs containing tenofovir disoproxil fumarate (TDF) are, we believe, putting patients at risk. This has resulted in HIV drug lawsuits from victims alleging kidney disease and failure, bone density loss, bone injuries, and other side effects.

Viread® and Truvada® are two of the first brand-name drugs developed by Gilead Sciences to treat HIV. Viread and Truvada both use tenofovir disoproxil fumarate (TDF), a new type of antiviral drug that was one of the first effective treatments for slowing HIV.

August 3, 2026

Bone Fracture Birth Injury Lawsuit

by Ronald V. Miller, Jr.

A broken bone discovered after childbirth does not automatically mean that the obstetric team committed malpractice. Clavicle, humerus, femur, and skull fractures can occur during a genuinely difficult delivery even when doctors and nurses respond appropriately. The legal question is how the fracture happened, whether the team used excessive force or misused an instrument, and whether a different response would probably have prevented the injury.

Most isolated newborn fractures heal well. The cases with the greatest medical and settlement consequences usually involve an associated brachial plexus injury, intracranial bleeding, brain damage, delayed diagnosis, permanent weakness, or developmental impairment. Parents need an honest assessment that separates a temporary fracture from the larger injury sometimes hidden behind it.

Our birth injury lawyers review cases involving fractures caused by shoulder dystocia, difficult extraction, forceps, vacuum devices, breech delivery, and delayed cesarean delivery. Call 800-553-8082 or contact us online for a free consultation.